Huge news from @OpenEvidence.
@MSKCancerCenter is one of the world's leading cancer centers, has partnered with @OpenEvidence to bring MSK's expertise to oncologists nationwide.
An amazing example of where @OpenEvidence is having real world impact on cancer patients nationwide!
Over 85% of oncologists at Memorial Sloan Kettering Cancer Center use OpenEvidence.
Together, @MSKCancerCenter and OpenEvidence have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence, putting it in the hands of oncologists across the United States.
As Dr. Anaeze Offodile puts it: “Our mission is to end cancer for life.” As of today, we are widening OncoKB’s reach so that patients everywhere benefit from the same rigor as patients at MSK. Watch the story.
The @recursive_si team just introduced Flint, a state-of-the-art local coding model. Flint is 2x faster than comparable models and was built in under four months — an impressive pace from an equally impressive team. Congrats @RichardSocher and the Recursive team!
Introducing Flint, @Recursive_SI’s first model: a fast local coding model built with our automated research system, the Eureka Machine.
• Best-in-class fast local coding
• Up to 2x faster than comparable models: 125+ tokens/sec on a MacBook Pro, 150+ on RTX Spark
• Built from scratch in under 4 months
Private, unmetered intelligence on your own machine. Open weights available now on @huggingface, run it locally on your favorite framework or try it for free on @opencode or @pidotdev.
In 2025, we agreed to lead @flappyairplanes' inception round over a glass of milk and a plate of sushi that may or may not have included the second vegetable that Ben had ever eaten in his life.
Flappy's team is brilliant and contrarian. Our thesis is that their breakthroughs in data- and compute-constrained environments will propel the American AI economy forward. It continues to be a privilege teaming with @spectorb and @amspector100 on this journey and we're honored to support them as the company's largest institutional investor. We look forward to partnering with them as they continue to fly ✈️
Congrats to @useblacksmith on its Series C!
In the past year, they have scaled from 16 million to 272 million completed CI jobs per month, and as CTO @aayush_shah15 explains, their infrastructure actually improves with scale.
Thrilled to keep supporting the team!
“What patients need is completely novel ideas, whether that’s modalities or biology or chemical structures. We need to have that balance, otherwise we won’t move medicine forward.”
At the @STATnews Summit, GV General Partner @schenkein shared his views on investing in innovation with @ADeAngelis_bio. #STATsummit
"The superfan is the lifeblood of an early-stage company."
At @TechCrunch Disrupt 2026, GV General Partner @crystalhuang shared tips to engage customers at the earliest stages of company building.
Watch the full conversation: youtube.com/watch?v=rmMo0upM…
Congratulations to GV portfolio company @estuarybio on its launch!
The team is developing gene therapies targeting the root cause of inherited kidney disease. We're proud to back their science-driven approach and mission to improve patients' lives.
Software was built for people or machines. @Attio is building for a future with both. Today, the team is introducing their hybrid architecture, a platform built for agentic revenue, designed for a world of people AND agents. Congrats to the whole team on this launch! 👏
In the age of agents, systems of record have never mattered more. They’ve also never been less prepared for what’s coming.
Today, we’re announcing @attio's hybrid architecture, with the controls of application software at the scale of infrastructure.
To agents, Attio looks like a database, queryable in SQL - a language they're RL’d on. Unlike a database, the business logic, policies, and compliance sit behind the query.
This makes all of Attio’s data accessible by agents in the most powerful and flexible syntax. It gives GTM teams an order of magnitude more value from their time, with the full power of agents working across the entire customer lifecycle.
A new shape of software is here.
attio.ai/architecture
GV retweeted
@amspector100, Ben and the @flappyairplanes team are going to take your breath away! After spending some time in their office and seeing under the hood, I couldnt be more pumped up for them! @GVteam is stoked to support them in any and every way!
Precision medicine has transformed cancer and rare disease care. @ArboretumLS is working to bring that approach to common diseases.
Meet the GV-incubated company, co-founded and led by GV General Partner Anthony Philippakis. Congrats to Anthony, Clare Bernard, and the team!
Congrats to GV portfolio companies @PelagePharma and EpiBiologics on being named to @FierceBiotech’s 2026 Fierce 15. From advancing a new approach to protein degradation to rethinking hair loss treatment, we’re excited to support both teams.
Read more about the 2026 Fierce 15: fiercebiotech.com/biotech/in…
As AI-generated content becomes more common on social, direct relationships with customers matter even more. @nectarsocialai co-founders @misbahuz and @farahura spoke with @bloomberg about what this shift could mean for platforms, brands, and trust online.
Huge news from @systalyze. The speed speaks for itself. ⚡
@systalyze is now #1 in output speed on @ArtificialAnlys, on every model we entered.
→ Gemma 4 26B: ~10× faster than Google
→ DeepSeek V4 Pro: 4× faster than DeepSeek
→ Muse Glimmer: 2.5× faster than Fireworks
Try it via our OpenAI-compatible API:
console.systalyze.com